Deliver Your News to the World

Business Conferences - ACUS, HEB


Due to the influx of emails StocksHaven Investments has been receiving on inquiries regarding the latest FDA deadlines on (Public, AMEX:HEB) and (Public, OTC:ACUS), StocksHaven Investments ( will be hosting a phone conference with Hemispherx BioPharma, inc. investor relations spokesperson. StocksHaven has requested the conversations to be recorded in real-time with no editing thus being publicized and is currently awaiting confirmation. StocksHaven Investments believe this will prove to be a new and ingenious implementation which will in turn help the company stand apart from other financial publications.

Here is a copy of the e-mail sent out to HEBís investor relations on May/12/09:

My name is Michael Vlaicu and I am the founder, and lead investment analyst of a highly successful financial blog and equity advice company. I would like to express my gratitude for your continued support and co-operation on your behalf. As I am a current shareholder and support your ongoing operations, it is in my best interest to give positive feedback to your shareholders on the current and future goals / plans of Hemixpherx Biopharma, Inc. Friday anytime past 3 pm EST would be suitable for me. Would it perhaps be possible to allow the voice conference to be recorded and publicized on my company webpage?

I expect the basis of our discussion will be with regards to the 18.3M at 1.10 PPS offering, although I am also interested in the ongoing pursuit to solidify Ampligen as a viable treatment for Chronic Fatigue Syndrome because there are currently no other FDA approved treatments. Moreover, your partnership with Oragens and the pursuit to develop treatments for HPV, HIV and other globally important viral diseases.

About StocksHaven Investments

StocksHaven Investments can be found at It is a news portal covering the world financial news and equities sector. It features its own blog, discussion forum, stock research reports, news feeds, mailing list, videos, press release capability, stock commentaries, and other unique content - including expert stock analysis from Michael Vlaicu.

For more financial and investment news, go to


 conference acus
 conference heb
 stock symbol acus
 stock symbol heb

This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.